CAS: 1476074-39-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-Quinolinecarboxamide, N-methyl-8-[(1S)-1-methyl-2-[(2'-methyl[4,5'-bipyrimidin]-6-yl-4',6'-d2)amino]ethyl]- REF: IN-DA001F09CAS: 1476074-39-1 | % | To inquire | Thu 12 Dec 24 |
 | VX-984 REF: TM-T11067CAS: 1476074-39-1 | 97.65% | 103.00 €~3,597.00 € | Thu 13 Mar 25 |
![4-Quinolinecarboxamide, N-methyl-8-[(1S)-1-methyl-2-[(2'-methyl[4,5'-bipyrimidin]-6-yl-4',6'-d2)am…](https://static.cymitquimica.com/products/IN/thumb/DA001F09.jpg)
4-Quinolinecarboxamide, N-methyl-8-[(1S)-1-methyl-2-[(2'-methyl[4,5'-bipyrimidin]-6-yl-4',6'-d2)amino]ethyl]-
CAS:1476074-39-1
Formula:
C23H21D2N7O
Purity:
%
Molecular weight:
415.4873
Ref: IN-DA001F09
| 5mg | 180.00 € | ||
| 10mg | 302.00 € | ||
| 25mg | 567.00 € | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 12 Dec 2024
VX-984
CAS:1476074-39-1
VX-984 (M9831) is an oral DNA-PK inhibitor, crossing the blood-brain barrier, targeting GBM and NSC-LC.
Formula:
C23H21D2N7O
Purity:
97.65%
Color and Shape:
Solid
Molecular weight:
415.49
Ref: TM-T11067
| 1mg | 103.00 € | ||
| 5mg | 256.00 € | ||
| 10mg | 378.00 € | ||
| 25mg | 596.00 € | ||
| 50mg | 804.00 € | ||
| 100mg | 1,078.00 € | ||
| 200mg | 1,452.00 € | ||
| 1mL*10mM (DMSO) | 275.00 € |
Estimated delivery in United States, on Thursday 13 Mar 2025
